Reduction in case fatality rate from meningococcal disease associated with improved Healthcare delivery

Archives of Disease in Childhood

Volumn 85, Issue 5, 2001, Pages 386-390

  Booy, R ^a   Habibi, P ^a   Nadel, S ^a   de Munter, C ^a   Britto, J ^a   Morrison, A ^a   Levin, M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Intensive care; Meningococcal disease; Survival

Indexed keywords

ADOLESCENT; AMBULATORY CARE; ARTICLE; BACTEREMIA; CHILD; FEMALE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; MALE; MEDICAL PROFESSION; MENINGOCOCCOSIS; MORTALITY; ORGANIZATION AND MANAGEMENT; PATIENT TRANSPORT; PRESCHOOL CHILD; STANDARD; STATISTICAL MODEL; SURVIVAL RATE; UNITED KINGDOM; UTILIZATION REVIEW;

ADOLESCENT; AMBULATORY CARE; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; LOGISTIC MODELS; LONDON; MALE; MENINGOCOCCAL INFECTIONS; QUALITY ASSURANCE, HEALTH CARE; REGIONAL MEDICAL PROGRAMS; SEVERITY OF ILLNESS INDEX; SPECIALISM; SURVIVAL RATE; TRANSPORTATION OF PATIENTS;

EID: 0035512794     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.85.5.386     Document Type: Article

References (27)

1. Jones D. Epidemiology of meningococcal disease in Europe and the USA. In: Cartwright K, ed. Meningococcal disease. New York: John Wiley & Sons, 1995:147-57.
2. Achtman M. Global epidemiology of meningococcal disease. In: Cartwright K, ed. Meningococcal disease. New York: John Wiley & Sons, 1995:159-75.
3. Havens PL, Garland JS, Brook MM, et al. Trends in mortality in children hospitalised with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J 1989;8:8-11.
4. Cartwright K. Introduction and historical aspects. In: Cartwright K, ed. Meningococcal disease. New York: John Wiley & Sons, 1995:1-9.
5. Duncan A. New therapies for severe meningococcal disease but better outcomes? Lancet 1997;350:1564-5.
6. Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996;15:967-79.
7. Derkx HHF, van den Hoek J, Redekop WK, et al. Meningococcal disease: a comparison of eight severity scores in 125 children. Intensive Care Med 1996;22:1433-41.
8. Leclerc F, Hazelzet J, Jude B, et al. Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensity Care Med 1992;18: 1-4.
9. Pollack MM, Ruttiman UE, Getson PR. Paediatric risk of mortality (PRISM) score. Crit Care Med 1988;16:1110-16.
10. Algren JT, Lal S, Cutliff SA, Richman B. Predictors of outcome in acute meningococcal infection in children. Crit Care Med 1993;21:447-52.
11. Goldman AP, Kerr SJ, Butt W, et al. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997;349:466-9.
12. Best C, Walsh J, Sinclair J, Beattie J. Early haemodiafiltration in meningococcal septicaemia. Lancet 1995; 347:202.
13. Zenz W, Muntean W, Gallisti S, et al. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Paediatrics 1995;96:144-8.
14. Smith OP, White B, Vaughan D, et al. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 1997; 350:1590-3.
15. Giroir BP, Quint PA, Barton P, et al. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability increasing protein in children with severe meningococcal sepsis. Lancet 1997;350:1439- 43.
16. Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood. In: Cartwright K, ed. Meningococcal disease. New York: John Wiley & Sons, 1995:207-43.
17. Pollack MM. Paediatric transport research: it is improving (finally). Crit Care Med 1994;22:1073-4.
18. Chief Medical Officer. Meningococcal septicaemia and meningitis. Circular to all medical practitioners in England and Wales, 1988.
19. Pollard AJ, Britto J, Nadel S, et al. Emergency management of meningococcal disease. Arch Dis Child 1999;80:290-6.
20. Pathan N, Nadel S, Levin M. Pathophysiology and management of meningococcal septicaemia. J R Coll Physicians Lond 2000;34:436-44.
21. Derkx B, Wittes J, McCLoskey R, and the European Pediatric Meningococcal Septic Shock Trial Study Group. Randomised, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. Clin Infect Dis 1999;28:770-7.
22. Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal/permeability-increasing protein (rBPI) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 2000;356:961-7.
23. Ramsay M, Kaczmaiski E, Rush M, et al. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. CDR Rev 1997;7:R49-54.
24. Tilford JM, Roberson PK, Lensing S, Fiser DH. Differences in paediatric ICU mortality risk over time. Crit Care Med 1998;26:1737-43.
25. Britto J, Nadel S, Maconochie I, et al. Morbidity and severity of illness during interhospital transfer: impact of a specialised paediatric retrieval team. BMJ 1995;311:836-9.
26. Paulson TE, Spear RM, Silva PD, et al. High-frequency pressure-control ventilation with high positive end- expiratory pressure in children with acute respiratory distress syndrome. J Pediatr 1996;129:566-73.
27. DeMunter C, Nadel S, Britto J, et al. ECMO for refractory cardiorespiratory failure due to meningococcal disease. Lancet 1997;349:1398.